+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines



Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines



Vaccine 22(29-30): 4101-4109



Two lineages of antigenically distinct equine influenza A H3N8 subtype viruses, American and European, co-circulate. Experiments were conducted in ponies to investigate the protection induced by vaccines containing virus from one lineage against challenge infection with homologous or heterologous virus. Regression analysis showed that vaccinated ponies with average pre-challenge single radial haemolysis (SRH) antibody levels (i.e. 45-190mm2) had a higher probability of becoming infected if they were vaccinated with virus heterologous to the challenge strain than if they were vaccinated with homologous virus. Field studies in Thoroughbred racehorses also showed that SRH antibody levels of >/= 150mm2 induced by vaccines containing a European lineage strain are protective against infection with a virus from the same lineage, but that the same or higher antibody levels may not be protective against an American lineage virus. In conclusion, vaccines should contain virus strains representative of both H3N8 subtype lineages to maximise protection against infection.

(PDF emailed within 0-6 h: $19.90)

Accession: 012063626

Download citation: RISBibTeXText

PMID: 15364463

DOI: 10.1016/j.vaccine.2004.02.048


Related references

Efficacy of equine influenza vaccines for protection against A/Equine/Jilin/89 (H3N8)--a new equine influenza virus. Vaccine 11(10): 987-993, 1993

Cocirculation of two distinct lineages of equine influenza virus subtype H3N8. Journal of Clinical Microbiology 37(9): 3005-3009, 1999

Identification of two antigenically and genetically distinct lineages of H3N8 equine influenza virus in Sweden. Epidemiology and Infection 120(1): 61-70, 1998

Phylogenetic and molecular characterization of equine H3N8 influenza viruses from Greece 23 and 27 Evidence for reassortment between evolutionary lineages. 2011

Protection against experimental infection with influenza virus A/equine/Miami/63 (H3N8) provided by inactivated whole virus vaccines containing homologous virus. Epidemiology and Infection 100(3): 501-510, 1988

Phylogenetic and molecular characterization of equine H3N8 influenza viruses from Greece (2003 and 2007): evidence for reassortment between evolutionary lineages. Virology Journal 8: 350, 2011

Cellular immune responses stimulated by inactivated virus vaccines and infection with equine influenza virus (H3N8). Equine infectious diseases VII: Proceedings of the Seventh International Conference, Tokyo, Japan 8th-11th June 1994: 169-174, 1994

Complete Genomic Sequences of H3N8 Equine Influenza Virus Strains Used as Vaccine Strains in Japan. Genome Announcements 6(12), 2018

Monoclonal antibody H3N8/11 against equine influenza H3N8 virus. Hybridoma: 1, 75, 2010

Complete Genome Sequencing of Two Equine Influenza A(H3N8) Virus Strains Isolated in Kazakhstan. Genome Announcements 6(26), 2018

Antibody responses induced by Japanese whole inactivated vaccines against equine influenza virus (H3N8) belonging to Florida sublineage clade2. Journal of Veterinary Medical Science 73(4): 483-485, 2011

Serological evidence of circulation of Equine H3N8 Influenza Virus in Algeria and its molecular characterization. Journal of Equine Veterinary Science 32(10): S11-S12, 2012

Equine influenza vaccine containing older H3N8 strains offers protection against A/eq/South Africa/4/03 (H3N8) strain in a short-term vaccine efficacy study. Equine Veterinary Journal 39(5): 446-450, 2007

Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8). Journal of Hygiene 90(3): 385-395, 1983

Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007. Veterinary Microbiology 138(1-2): 41-52, 2009